Antigen presenting cell targeted antiviral vaccines

Details for Australian Patent Application No. 2010222929 (hide)

Owner Baylor Research Institute

Inventors Zurawski, Gerard; Banchereau, Jacques F.; Flamar, Anne-Laure; Levy, Yves; Montes, Monica

Agent Pizzeys

Pub. Number AU-A-2010222929

PCT Pub. Number WO2010/104748

Priority 61/159,062 10.03.09 US; 61/159,059 10.03.09 US; 61/159,055 10.03.09 US; 12/717,804 04.03.10 US

Filing date 4 March 2010

Wipo publication date 16 September 2010

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/104748 Priority application(s): WO2010/104748

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010222930-Antigen presenting cell targeted cancer vaccines

2010222928-Antigen presenting cell targeted vaccines